Non-conjunctival Ocular Adnexal Malt Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-06
Clinical Trial Update: R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML) [Phase 2]
Phase 2 clinical trial update evaluating R-CVP for non-conjunctival ocular adnexal MALT lymphoma (OAML) has completed.